Owl Creek Asset Management, L.P. - Sep 29, 2023 Form 4 Insider Report for Estrella Immunopharma, Inc. (UPTD)

Role
10%+ Owner
Signature
Owl Creek Asset Management, L.P. By: /s/ Owl Creek GP, L.L.C., its general partner By: /s/ Jeffrey A. Altman, Managing Member
Stock symbol
UPTD
Transactions as of
Sep 29, 2023
Transactions value $
-$2,769,300
Form type
4
Date filed
10/5/2023, 04:15 PM
Previous filing
Sep 26, 2023
Next filing
Oct 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UPTD Common Stock, par value $0.0001 per share Other -$2.77M -255K -100% $10.86 0 Sep 29, 2023 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Owl Creek Asset Management, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 In connection with the closing of the Issuer's business combination, the shares held by OCCOMF (as defined below) were redeemed.
F2 The securities to which this filing relates are held directly by Owl Creek Credit Opportunities Master Fund, L.P., a Cayman Islands exempted limited partnership ("OCCOMF"), to which Owl Creek Asset Management, L.P., a Delaware limited partnership (the "Investment Manager"), serves as investment manager. Jeffrey A. Altman ("Mr. Altman") is the managing member of the general partner of the Investment Manager. Each of the Investment Manager and Mr. Altman disclaims beneficial ownership of the securities to which this filing relates for purposes of Section 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any.